Full Text View
Tabular View
No Study Results Posted
Related Studies
Use of Activated Recombinant Human Factor VII to Reduce Bleeding Caused by Warfarin Treatment
This study has been completed.
Study NCT01561937   Information provided by Novo Nordisk

First Received on March 21, 2012.   Last Updated on March 22, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Haemostasis
Healthy
Additional conditions recognized in this trial
Hemorrhage
More general conditions related to this trial
Pathologic Processes
Interventions listed in this trial
warfarin
placebo
More general drug interventions related to this trial
Anticoagulants
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Novo Nordisk


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services